Sep 20, 2022
Efient Tabs 10mg 28 first appeared in Wavedata’s data, collected from pharmacies and dispensing doctors, in April 2011. Parallel Imports appeared before UK packs, which suggests there was a period during which Efient was sold to pharmacies through linked systems...
Sep 15, 2022
Boom bust cycles exist for up to 81% of generics as market competition forces prices down to levels which cannot be profitably be sustained by manufacturers, at which some stop manufacturing. This leads to a reduction in the stock available to dispense, followed by a...
Sep 13, 2022
In theory, a product which is due to expire very soon should be offered to pharmacies at a large discount, whereas a product with many months of life remaining should only have a small discount. However, in this analysis and in others we’ve run in the past this...
Sep 7, 2022
Price bounces happen after the originator product (Migard Tabs 2.5mg 6 in this case) loses its exclusivity (LOE) and generics have been launched. The market price of the generic can fall very quickly if there are lots of generic licence holders. However, where product...
Sep 6, 2022
Generic versions of Galvus are due to be launched by generic manufacturers in the coming weeks, so what is the future for Vildagliptin? There is a ‘honeymoon’ period after generics are launched during which the original brand manufacturer can profitably...
Aug 30, 2022
In light of the increases to the rebates that branded and brand-generic manufacturers have to return to the NHS under the VPAS voluntary and statutory schemes, with forecast rebates of 25% in 2023 we thought it worth having a look at the amount of effort each type of...
